Work

P108 Baseline characteristics and efficacy outcomes of patients with long-term exposure to enzalutamide during the Phase III AFFIRM trial

Year: 2013

Type: conference-abstract

Source: European Urology Supplements

DOI: 10.1016/s1569-9056(13)62433-1

Authors: J.S. De Bono, M.T. Fleming, K. Fizazi, M.-E. Taplin, D. Forer, M. Hirmand, H.I. Scher

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1973834885

Cites:

Cited by:

Related to: 10